SCHEMBL19923643

SCHEMBL19923643

CC[Si](CC)(CC)N1C(=O)C(c2ccccc2)N([Si](CC)(CC)CC)C1=O

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ATM Q13315 1/20 0.37
LMNA P02545 4/20 0.36
ADORA3 P0DMS8 1/20 0.36
KMT2A Q03164 3/20 0.34
MMP2 P08253 3/20 0.34
MEN1 O00255 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
POLB P06746 1/20 0.33
ALDH1A1 P00352 2/20 0.33
GFER P55789 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TSHR P16473 2/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923704 0.84 LMNA (0.45) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923555 0.83 LMNA (0.39) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923511 0.82 ADRA2A (0.39) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923545 0.82 CYP1A2 (0.44) SMN1; SMN2NPSR1LMNAADORA3KMT2A
SCHEMBL19923443 0.81 LMNA (0.34) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923492 0.80 EHMT2 (0.46) KMT2AMEN1ALDH1A1KDM4ETSHR
SCHEMBL19923657 0.76 ALDH1A1 (0.49) NPSR1LMNAKMT2AMEN1CYP2C9
SCHEMBL19923690 0.76 MMP2 (0.36) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923526 0.74 LMNA (0.44) SMN1; SMN2NPSR1ATMLMNAADORA3
SCHEMBL19923724 0.73 MMP2 (0.35) SMN1; SMN2NPSR1ATMLMNAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN SMN1; SMN2 1697/4885NPSR1 1322/4885ATM 2253/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM SMN1; SMN2 1924/4885NPSR1 1281/4885ATM 2378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.